Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 0.71% 1,416.00 1,416.00 1,416.50 1,423.50 1,398.00 1,414.00 2,644,740 16:29:55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3,335.3 179.9 37.5 38.0 12,400

Smith & Nephew Share Discussion Threads

Showing 951 to 974 of 975 messages
Chat Pages: 39  38  37  36  35  34  33  32  31  30  29  28  Older
DateSubjectAuthorDiscuss
06/4/2021
20:48
Every little helps! US cracking on with their vaccinations too...
hubshank
06/4/2021
14:26
This is a global organisation, UK a relatively small part of revenue.
essentialinvestor
01/4/2021
12:04
My local paper has just run an article saying more than 2,200 covid patients discharged and now focussing on procedure wiating list. London will be doing the same as I saw article other day saying no new cases in London.
hubshank
01/4/2021
09:52
Added as well. Poor sentiment and expected newsflow very much in the price. Any slight expectation of a pick up or bid and we could be 20% higher quite quickly. Hopefully the downside is limited.
its the oxman
31/3/2021
22:08
Welcome aboard.
timbo_slice
31/3/2021
18:36
Bought in. Elective surgery should surge during the summer. Can see this returning to the 1600-1700p range.
justiceforthemany
10/3/2021
18:01
Susceptible to a bid from Stryker I think!
ianood
10/3/2021
12:14
Yep, great industry to be in, will hugely benefit from an aging population
spoole5
10/3/2021
10:22
Depressed by covid, fundamental value remains and agree a bid is more likely than ever.
its the oxman
03/3/2021
14:51
Will be vulnerable to a bid soon at these levels
spoole5
03/3/2021
14:40
Pricy still.
essentialinvestor
02/3/2021
15:10
Good to see clarification of the multiples I posted last week. As someone mentioned to me who disputed the figures ...perhaps it's about the quality of your information. Yes, perhaps it is.
essentialinvestor
02/3/2021
13:25
Questor: Smith & Nephew may have grazed its knees with Covid, but it has plenty of fight left Questor share tip: cancelled surgeries have reduced the need for medical supplies, but demand could well bounce back after lockdown Smith & Nephew could deliver some pleasant surprises in 2021 and beyond. Hold. Questor says: hold https://www.telegraph.co.uk/investing/shares/questor-smith-nephew-may-have-grazed-knees-covid-has-plenty/
philanderer
25/2/2021
13:56
With defensive qualities 30% in 2 years will do me.
piano man
23/2/2021
16:37
Unlikely to take 2 years
spoole5
23/2/2021
16:31
My Dad uses professional data, will check with him but he's not available atm. To make USD1.85, that's an 80% increase on FY 2019, I can't square that number with anything I've looked at. The 2019 FY is pre Covid-19 earnings.
essentialinvestor
23/2/2021
16:24
My source gives a consensus forecast PE of US$1.85, approx £1.30, so around 11 times at £14.
gclark
23/2/2021
16:23
That's peak pre Covid-19 earnings. You are looking at a 2 year recovery to get back to that?.
essentialinvestor
23/2/2021
16:21
Just under 20 not overly expensive given the significant growth opportunities
spoole5
23/2/2021
16:17
Well I'm looking at the adjusted EPS for 2019 at $1.02 (which allows for any (exceptionals). year ending 31/12/2019 - pre Covid-19 hitting. On current FX that gives a PE of just under 20 X. How are you getting 10 X earnings.
essentialinvestor
23/2/2021
16:11
I see it on a forward forecast PE for 2021 of 10, at a share price of £14, which is not steep. xxx://money.cnn.com/quote/forecast/forecast.html?symb=SNN It seems like a decent source of information but we are all limited by our information source!
gclark
23/2/2021
13:53
spoole, I've looked at FY 2018 EPS, which was the recent peak and flattered by a legal settlement and still get what appears a pricy multiple. As SN report in USD, you need to convert earnings in to GBP to calculate.
essentialinvestor
23/2/2021
13:48
I don't think anyone can accurately predict any earnings for companies hit by covid.
spoole5
23/2/2021
13:30
* 24 X FY 2022 earnings estimates, I've not got FY 2023 numbers.
essentialinvestor
Chat Pages: 39  38  37  36  35  34  33  32  31  30  29  28  Older
ADVFN Advertorial
Your Recent History
LSE
SN.
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210414 19:09:01